Home|Journals|Articles by Year|Audio Abstracts

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2010; 6(1): 107-115


Afaf M. Amin Amani H. Kazem Safia M. Hassan Eman A. Youssef Eman M. Khalil.


Liver fibrosis is considered as a dynamic and highly integrated cellular response to chronic liver injury. The present study was designed to determine the possible protective effect of silymarin on hepatic fibrosis induced by carbon tetrachloride (CCl4) injections in rats. Seventy male Sprague-Dawely rats were divided into 3 groups; group I (control n=10), rats of group II (n= 30) were injected with CCl4 intra-peritoneally in a dose of 1.0 ml/kg BW for three doses weekly, each other, for 12 weeks and rats of group III (n= 30) were injected with CCl4 as in group II and treated with silymarin in a daily oral dose of 50 mg/kg BW for 12 weeks. Rats were sacrificed after 4, 8 and 12 weeks and liver was quickly dissected out. Liver specimens were subjected to routine H &E stain and immunohistochemical stain of proliferating cell nuclear antigen (PCNA). The histopathological results showed that CCl4 revealed necrotic and vacuolated hepatocytes as well as dilation and congestion in both sinusoids and in the branches of the portal vein. These alterations were marked in addition to portal fibrosis after 12 weeks. Silymarin treatment reduced the impaired hepatic changes induced by CCl4 as evidenced in hepatocytes regeneration and decreased inflammation and congestion. Immunohistochemical results showed time-dependant increase in PCNA expression in CCl4 injected group and it was more significant in CCl4- silymarin treated group. It was concluded that silymarin has a hepatoprotective effect in rats with liver injury induced by CCl4 where it improved hepatic structure through the stimulation of liver regeneration and alleviated liver fibrosis by its anti-fibrotic role.

Key words: CCl4, Silymarin, Rats, Liver, Histopathology, PCNA

Full-text options

Share this Article

Online Article Submission
• ejmanager.com
• ojshosting.net

Do you want to use OJS for your journal ?
work with an experienced partner

Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.